Giovanni Mazzarol

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

Viviana Galimberti, Bernard F. Cole, Stefano Zurrida et al. · The Lancet Oncology · 2013 · 1.2K citations · Full text

Medicine, Oncology, Surgery +13

Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content

Salvatore Pece, Daniela Tosoni, Stefano Confalonieri et al. · Cell · 2010 · 956 citations · Full text

Medicine, Cancer Biology, Oncology +16

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

Medicine, Oncology, Surgery +17

Sentinel Lymph Node Biopsy in Breast Cancer

Umberto Veronesi, Giuseppe Viale, Giovanni Paganelli et al. · Annals of Surgery · 2010 · 547 citations

Medicine, Pathology, Surgery +17

Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study

Umberto Veronesi, Giovanni Paganelli, Giuseppe Viale et al. · The Lancet Oncology · 2006 · 486 citations

Medicine, Oncology, Surgery +16